Overview
LEGN market data
Price History
LEGN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.81 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.57 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -22.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.24 – $38.35 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.9B · P/B 3.97 · P/S 3.45.
Company News
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For WednesdayBenzinga · Aug 12, 2026, 4:18 PM
Morgan Stanley Maintains Overweight on Legend Biotech, Raises Price Target to $49Benzinga · Aug 12, 2026, 3:51 PM
TD Cowen Maintains Hold on Legend Biotech, Lowers Price Target to $24Benzinga · Aug 12, 2026, 3:18 PM
Oppenheimer Downgrades Legend Biotech to Perform, Lowers Price Target to $40Benzinga · Aug 12, 2026, 2:55 PM
RBC Capital Maintains Outperform on Legend Biotech, Lowers Price Target to $58Benzinga · Aug 12, 2026, 2:07 PM
Barclays Maintains Overweight on Legend Biotech, Lowers Price Target to $78Benzinga · Aug 12, 2026, 12:33 PM
Legend Biotech shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Aug 11, 2026, 11:56 AM
Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M EstimateBenzinga · Aug 11, 2026, 11:02 AM
Top 3 Health Care Stocks You'll Regret Missing This QuarterBenzinga · Aug 4, 2026, 10:04 AM
HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $65 Price TargetBenzinga · Jul 28, 2026, 10:17 AM